Albumin (as Excipient) Industry Research Report 2023

Albumin (as Excipient) Industry Research Report 2023


Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

Highlights

The global Albumin (as Excipient) market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Albumin (as Excipient), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (as Excipient).
The Albumin (as Excipient) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Albumin (as Excipient) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (as Excipient) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia

Product Type Insights

Global markets are presented by Albumin (as Excipient) type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Albumin (as Excipient) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Albumin (as Excipient) segment by Type

Human Serum Albumin
Recombinant Albumin

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Albumin (as Excipient) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Albumin (as Excipient) market.
Albumin (as Excipient) segment by Application

Cell Culture Media
Medical Supplements
Therapeutics

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Albumin (as Excipient) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin (as Excipient) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Albumin (as Excipient) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Albumin (as Excipient) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin (as Excipient).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Albumin (as Excipient) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Albumin (as Excipient) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Albumin (as Excipient) Market Size (2018-2029) & (US$ Million)
2.2.2 Global Albumin (as Excipient) Sales (2018-2029)
2.2.3 Global Albumin (as Excipient) Market Average Price (2018-2029)
2.3 Albumin (as Excipient) by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
2.4 Albumin (as Excipient) by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Cell Culture Media
2.4.3 Medical Supplements
2.4.4 Therapeutics
3 Market Competitive Landscape by Manufacturers
3.1 Global Albumin (as Excipient) Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Albumin (as Excipient) Sales (MT) of Manufacturers (2018-2023)
3.3 Global Albumin (as Excipient) Revenue of Manufacturers (2018-2023)
3.4 Global Albumin (as Excipient) Average Price by Manufacturers (2018-2023)
3.5 Global Albumin (as Excipient) Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Albumin (as Excipient), Product Type & Application
3.8 Global Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
3.9 Global Albumin (as Excipient) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 CSL
4.1.1 CSL Company Information
4.1.2 CSL Business Overview
4.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.1.4 CSL Albumin (as Excipient) Product Portfolio
4.1.5 CSL Recent Developments
4.2 Grifols
4.2.1 Grifols Company Information
4.2.2 Grifols Business Overview
4.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Grifols Albumin (as Excipient) Product Portfolio
4.2.5 Grifols Recent Developments
4.3 Takeda
4.3.1 Takeda Company Information
4.3.2 Takeda Business Overview
4.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Takeda Albumin (as Excipient) Product Portfolio
4.3.5 Takeda Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Octapharma Albumin (as Excipient) Product Portfolio
4.4.5 Octapharma Recent Developments
4.5 Hualan Bio
4.5.1 Hualan Bio Company Information
4.5.2 Hualan Bio Business Overview
4.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hualan Bio Albumin (as Excipient) Product Portfolio
6.5.5 Hualan Bio Recent Developments
4.6 CBPO
4.6.1 CBPO Company Information
4.6.2 CBPO Business Overview
4.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.6.4 CBPO Albumin (as Excipient) Product Portfolio
4.6.5 CBPO Recent Developments
4.7 Shanghai RAAS
4.7.1 Shanghai RAAS Company Information
4.7.2 Shanghai RAAS Business Overview
4.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Shanghai RAAS Albumin (as Excipient) Product Portfolio
4.7.5 Shanghai RAAS Recent Developments
6.8 Kedrion
4.8.1 Kedrion Company Information
4.8.2 Kedrion Business Overview
4.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Kedrion Albumin (as Excipient) Product Portfolio
4.8.5 Kedrion Recent Developments
4.9 LFB Group
4.9.1 LFB Group Company Information
4.9.2 LFB Group Business Overview
4.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.9.4 LFB Group Albumin (as Excipient) Product Portfolio
4.9.5 LFB Group Recent Developments
4.10 Albumedix
4.10.1 Albumedix Company Information
4.10.2 Albumedix Business Overview
4.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Albumedix Albumin (as Excipient) Product Portfolio
4.10.5 Albumedix Recent Developments
6.11 Biotest
6.11.1 Biotest Company Information
6.11.2 Biotest Albumin (as Excipient) Business Overview
6.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Biotest Albumin (as Excipient) Product Portfolio
6.11.5 Biotest Recent Developments
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Albumin (as Excipient) Business Overview
6.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Merck Albumin (as Excipient) Product Portfolio
6.12.5 Merck Recent Developments
6.13 Ventria (InVitria)
6.13.1 Ventria (InVitria) Company Information
6.13.2 Ventria (InVitria) Albumin (as Excipient) Business Overview
6.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Ventria (InVitria) Albumin (as Excipient) Product Portfolio
6.13.5 Ventria (InVitria) Recent Developments
6.14 HiMedia
6.14.1 HiMedia Company Information
6.14.2 HiMedia Albumin (as Excipient) Business Overview
6.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)
6.14.4 HiMedia Albumin (as Excipient) Product Portfolio
6.14.5 HiMedia Recent Developments
5 Global Albumin (as Excipient) Market Scenario by Region
5.1 Global Albumin (as Excipient) Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Albumin (as Excipient) Sales by Region: 2018-2029
5.2.1 Global Albumin (as Excipient) Sales by Region: 2018-2023
5.2.2 Global Albumin (as Excipient) Sales by Region: 2024-2029
5.3 Global Albumin (as Excipient) Revenue by Region: 2018-2029
5.3.1 Global Albumin (as Excipient) Revenue by Region: 2018-2023
5.3.2 Global Albumin (as Excipient) Revenue by Region: 2024-2029
5.4 North America Albumin (as Excipient) Market Facts & Figures by Country
5.4.1 North America Albumin (as Excipient) Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Albumin (as Excipient) Sales by Country (2018-2029)
5.4.3 North America Albumin (as Excipient) Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Albumin (as Excipient) Market Facts & Figures by Country
5.5.1 Europe Albumin (as Excipient) Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Albumin (as Excipient) Sales by Country (2018-2029)
5.5.3 Europe Albumin (as Excipient) Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Albumin (as Excipient) Market Facts & Figures by Country
5.6.1 Asia Pacific Albumin (as Excipient) Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Albumin (as Excipient) Sales by Country (2018-2029)
5.6.3 Asia Pacific Albumin (as Excipient) Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Albumin (as Excipient) Market Facts & Figures by Country
5.7.1 Latin America Albumin (as Excipient) Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Albumin (as Excipient) Sales by Country (2018-2029)
5.7.3 Latin America Albumin (as Excipient) Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Albumin (as Excipient) Market Facts & Figures by Country
5.8.1 Middle East and Africa Albumin (as Excipient) Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Albumin (as Excipient) Sales by Country (2018-2029)
5.8.3 Middle East and Africa Albumin (as Excipient) Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Albumin (as Excipient) Sales by Type (2018-2029)
6.1.1 Global Albumin (as Excipient) Sales by Type (2018-2029) & (MT)
6.1.2 Global Albumin (as Excipient) Sales Market Share by Type (2018-2029)
6.2 Global Albumin (as Excipient) Revenue by Type (2018-2029)
6.2.1 Global Albumin (as Excipient) Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Albumin (as Excipient) Revenue Market Share by Type (2018-2029)
6.3 Global Albumin (as Excipient) Price by Type (2018-2029)
7 Segment by Application
7.1 Global Albumin (as Excipient) Sales by Application (2018-2029)
7.1.1 Global Albumin (as Excipient) Sales by Application (2018-2029) & (MT)
7.1.2 Global Albumin (as Excipient) Sales Market Share by Application (2018-2029)
7.2 Global Albumin (as Excipient) Revenue by Application (2018-2029)
6.2.1 Global Albumin (as Excipient) Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Albumin (as Excipient) Revenue Market Share by Application (2018-2029)
7.3 Global Albumin (as Excipient) Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Albumin (as Excipient) Value Chain Analysis
8.1.1 Albumin (as Excipient) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Albumin (as Excipient) Production Mode & Process
8.2 Albumin (as Excipient) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Albumin (as Excipient) Distributors
8.2.3 Albumin (as Excipient) Customers
9 Global Albumin (as Excipient) Analyzing Market Dynamics
9.1 Albumin (as Excipient) Industry Trends
9.2 Albumin (as Excipient) Industry Drivers
9.3 Albumin (as Excipient) Industry Opportunities and Challenges
9.4 Albumin (as Excipient) Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Albumin (as Excipient) Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Albumin (as Excipient) Sales (MT) of Manufacturers (2018-2023)
Table 7. Global Albumin (as Excipient) Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Albumin (as Excipient) Revenue of Manufacturers (2018-2023)
Table 9. Global Albumin (as Excipient) Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Albumin (as Excipient) Average Price (USD/Kg) of Manufacturers (2018-2023)
Table 11. Global Albumin (as Excipient) Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Albumin (as Excipient), Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Albumin (as Excipient) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. CSL Company Information
Table 17. CSL Business Overview
Table 18. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 19. CSL Albumin (as Excipient) Product Portfolio
Table 20. CSL Recent Developments
Table 21. Grifols Company Information
Table 22. Grifols Business Overview
Table 23. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 24. Grifols Albumin (as Excipient) Product Portfolio
Table 25. Grifols Recent Developments
Table 26. Takeda Company Information
Table 27. Takeda Business Overview
Table 28. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 29. Takeda Albumin (as Excipient) Product Portfolio
Table 30. Takeda Recent Developments
Table 31. Octapharma Company Information
Table 32. Octapharma Business Overview
Table 33. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 34. Octapharma Albumin (as Excipient) Product Portfolio
Table 35. Octapharma Recent Developments
Table 36. Hualan Bio Company Information
Table 37. Hualan Bio Business Overview
Table 38. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 39. Hualan Bio Albumin (as Excipient) Product Portfolio
Table 40. Hualan Bio Recent Developments
Table 41. CBPO Company Information
Table 42. CBPO Business Overview
Table 43. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 44. CBPO Albumin (as Excipient) Product Portfolio
Table 45. CBPO Recent Developments
Table 46. Shanghai RAAS Company Information
Table 47. Shanghai RAAS Business Overview
Table 48. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 49. Shanghai RAAS Albumin (as Excipient) Product Portfolio
Table 50. Shanghai RAAS Recent Developments
Table 51. Kedrion Company Information
Table 52. Kedrion Business Overview
Table 53. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 54. Kedrion Albumin (as Excipient) Product Portfolio
Table 55. Kedrion Recent Developments
Table 56. LFB Group Company Information
Table 57. LFB Group Business Overview
Table 58. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 59. LFB Group Albumin (as Excipient) Product Portfolio
Table 60. LFB Group Recent Developments
Table 61. Albumedix Company Information
Table 62. Albumedix Business Overview
Table 63. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 64. Albumedix Albumin (as Excipient) Product Portfolio
Table 65. Albumedix Recent Developments
Table 66. Biotest Company Information
Table 67. Biotest Business Overview
Table 68. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 69. Biotest Albumin (as Excipient) Product Portfolio
Table 70. Biotest Recent Developments
Table 71. Merck Company Information
Table 72. Merck Business Overview
Table 73. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 74. Merck Albumin (as Excipient) Product Portfolio
Table 75. Merck Recent Developments
Table 76. Ventria (InVitria) Company Information
Table 77. Ventria (InVitria) Business Overview
Table 78. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 79. Ventria (InVitria) Albumin (as Excipient) Product Portfolio
Table 80. Ventria (InVitria) Recent Developments
Table 81. HiMedia Company Information
Table 82. HiMedia Business Overview
Table 83. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 84. HiMedia Albumin (as Excipient) Product Portfolio
Table 85. HiMedia Recent Developments
Table 86. Global Albumin (as Excipient) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 87. Global Albumin (as Excipient) Sales by Region (2018-2023) & (MT)
Table 88. Global Albumin (as Excipient) Sales Market Share by Region (2018-2023)
Table 89. Global Albumin (as Excipient) Sales by Region (2024-2029) & (MT)
Table 90. Global Albumin (as Excipient) Sales Market Share by Region (2024-2029)
Table 91. Global Albumin (as Excipient) Revenue by Region (2018-2023) & (US$ Million)
Table 92. Global Albumin (as Excipient) Revenue Market Share by Region (2018-2023)
Table 93. Global Albumin (as Excipient) Revenue by Region (2024-2029) & (US$ Million)
Table 94. Global Albumin (as Excipient) Revenue Market Share by Region (2024-2029)
Table 95. North America Albumin (as Excipient) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. North America Albumin (as Excipient) Sales by Country (2018-2023) & (MT)
Table 97. North America Albumin (as Excipient) Sales by Country (2024-2029) & (MT)
Table 98. North America Albumin (as Excipient) Revenue by Country (2018-2023) & (US$ Million)
Table 99. North America Albumin (as Excipient) Revenue by Country (2024-2029) & (US$ Million)
Table 100. Europe Albumin (as Excipient) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Europe Albumin (as Excipient) Sales by Country (2018-2023) & (MT)
Table 102. Europe Albumin (as Excipient) Sales by Country (2024-2029) & (MT)
Table 103. Europe Albumin (as Excipient) Revenue by Country (2018-2023) & (US$ Million)
Table 104. Europe Albumin (as Excipient) Revenue by Country (2024-2029) & (US$ Million)
Table 105. Asia Pacific Albumin (as Excipient) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Asia Pacific Albumin (as Excipient) Sales by Country (2018-2023) & (MT)
Table 107. Asia Pacific Albumin (as Excipient) Sales by Country (2024-2029) & (MT)
Table 108. Asia Pacific Albumin (as Excipient) Revenue by Country (2018-2023) & (US$ Million)
Table 109. Asia Pacific Albumin (as Excipient) Revenue by Country (2024-2029) & (US$ Million)
Table 110. Latin America Albumin (as Excipient) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Latin America Albumin (as Excipient) Sales by Country (2018-2023) & (MT)
Table 112. Latin America Albumin (as Excipient) Sales by Country (2024-2029) & (MT)
Table 113. Latin America Albumin (as Excipient) Revenue by Country (2018-2023) & (US$ Million)
Table 114. Latin America Albumin (as Excipient) Revenue by Country (2024-2029) & (US$ Million)
Table 115. Middle East and Africa Albumin (as Excipient) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Middle East and Africa Albumin (as Excipient) Sales by Country (2018-2023) & (MT)
Table 117. Middle East and Africa Albumin (as Excipient) Sales by Country (2024-2029) & (MT)
Table 118. Middle East and Africa Albumin (as Excipient) Revenue by Country (2018-2023) & (US$ Million)
Table 119. Middle East and Africa Albumin (as Excipient) Revenue by Country (2024-2029) & (US$ Million)
Table 120. Global Albumin (as Excipient) Sales by Type (2018-2023) & (MT)
Table 121. Global Albumin (as Excipient) Sales by Type (2024-2029) & (MT)
Table 122. Global Albumin (as Excipient) Sales Market Share by Type (2018-2023)
Table 123. Global Albumin (as Excipient) Sales Market Share by Type (2024-2029)
Table 124. Global Albumin (as Excipient) Revenue by Type (2018-2023) & (US$ Million)
Table 125. Global Albumin (as Excipient) Revenue by Type (2024-2029) & (US$ Million)
Table 126. Global Albumin (as Excipient) Revenue Market Share by Type (2018-2023)
Table 127. Global Albumin (as Excipient) Revenue Market Share by Type (2024-2029)
Table 128. Global Albumin (as Excipient) Price by Type (2018-2023) & (USD/Kg)
Table 129. Global Albumin (as Excipient) Price by Type (2024-2029) & (USD/Kg)
Table 130. Global Albumin (as Excipient) Sales by Application (2018-2023) & (MT)
Table 131. Global Albumin (as Excipient) Sales by Application (2024-2029) & (MT)
Table 132. Global Albumin (as Excipient) Sales Market Share by Application (2018-2023)
Table 133. Global Albumin (as Excipient) Sales Market Share by Application (2024-2029)
Table 134. Global Albumin (as Excipient) Revenue by Application (2018-2023) & (US$ Million)
Table 135. Global Albumin (as Excipient) Revenue by Application (2024-2029) & (US$ Million)
Table 136. Global Albumin (as Excipient) Revenue Market Share by Application (2018-2023)
Table 137. Global Albumin (as Excipient) Revenue Market Share by Application (2024-2029)
Table 138. Global Albumin (as Excipient) Price by Application (2018-2023) & (USD/Kg)
Table 139. Global Albumin (as Excipient) Price by Application (2024-2029) & (USD/Kg)
Table 140. Key Raw Materials
Table 141. Raw Materials Key Suppliers
Table 142. Albumin (as Excipient) Distributors List
Table 143. Albumin (as Excipient) Customers List
Table 144. Albumin (as Excipient) Industry Trends
Table 145. Albumin (as Excipient) Industry Drivers
Table 146. Albumin (as Excipient) Industry Restraints
Table 147. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Albumin (as Excipient)Product Picture
Figure 5. Global Albumin (as Excipient) Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Albumin (as Excipient) Market Size (2018-2029) & (US$ Million)
Figure 7. Global Albumin (as Excipient) Sales (2018-2029) & (MT)
Figure 8. Global Albumin (as Excipient) Average Price (USD/Kg) & (2018-2029)
Figure 9. Human Serum Albumin Product Picture
Figure 10. Recombinant Albumin Product Picture
Figure 11. Cell Culture Media Product Picture
Figure 12. Medical Supplements Product Picture
Figure 13. Therapeutics Product Picture
Figure 14. Global Albumin (as Excipient) Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Albumin (as Excipient) Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Albumin (as Excipient) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Albumin (as Excipient) Sales by Region in 2022
Figure 21. Global Albumin (as Excipient) Revenue by Region in 2022
Figure 22. North America Albumin (as Excipient) Market Size by Country in 2022
Figure 23. North America Albumin (as Excipient) Sales Market Share by Country (2018-2029)
Figure 24. North America Albumin (as Excipient) Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Albumin (as Excipient) Market Size by Country in 2022
Figure 28. Europe Albumin (as Excipient) Sales Market Share by Country (2018-2029)
Figure 29. Europe Albumin (as Excipient) Revenue Market Share by Country (2018-2029)
Figure 30. Germany Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Albumin (as Excipient) Market Size by Country in 2022
Figure 36. Asia Pacific Albumin (as Excipient) Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Albumin (as Excipient) Revenue Market Share by Country (2018-2029)
Figure 38. China Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Albumin (as Excipient) Market Size by Country in 2022
Figure 48. Latin America Albumin (as Excipient) Sales Market Share by Country (2018-2029)
Figure 49. Latin America Albumin (as Excipient) Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Albumin (as Excipient) Market Size by Country in 2022
Figure 54. Middle East and Africa Albumin (as Excipient) Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Albumin (as Excipient) Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Albumin (as Excipient) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Albumin (as Excipient) Sales Market Share by Type (2018-2029)
Figure 60. Global Albumin (as Excipient) Revenue Market Share by Type (2018-2029)
Figure 61. Global Albumin (as Excipient) Price (USD/Kg) by Type (2018-2029)
Figure 62. Global Albumin (as Excipient) Sales Market Share by Application (2018-2029)
Figure 63. Global Albumin (as Excipient) Revenue Market Share by Application (2018-2029)
Figure 64. Global Albumin (as Excipient) Price (USD/Kg) by Application (2018-2029)
Figure 65. Albumin (as Excipient) Value Chain
Figure 66. Albumin (as Excipient) Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Albumin (as Excipient) Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings